top of page
.png)
InformAI News
InformAI Receives FDA 510(k) Clearance for RadOncAI Radiation Therapy Dose Planning Software
AI-powered SaMD streamlines radiation therapy dose planning for head & neck cancers HOUSTON, TX, UNITED STATES, July 15, 2026 /EINPresswire.com/ InformAI, Inc., a leader in innovative medical technology, is proud to announce that it has received 510(k) approval from the U.S. Food and Drug Administration (FDA) to market an AI-enabled radiation therapy dose planning software, RadOncAI™. This clinician co-pilot software-as-a-medical-device uses artificial intelligence (AI) to o
Jun 18
bottom of page